Presented by Courtenay Gilmore Wilson, PharmD, BCPS, BCACP, CDE, CPP
In this module Dr. Gilmore Wilson helps pharmacists understand that with repeated use of a substance, the brain changes and results in cravings and compulsive use of a substance despite negative consequences resulting in a substance use disorder. She then discusses the three medications currently approved to treat opioid use disorder, methadone, buprenorphine, and naltrexone. This video is a project of the Governor’s Institute supported by the through funding from the Division of Mental Health, Developmental Disabilities and Substances Abuse Services, Substance Abuse and Mental Health Services Administration, Strategic Prevention Framework for Prescription Drugs (CFDA #93.243), North Carolina Division of Public Health Injury and Violence Prevention Branch and the Centers for Disease Control. Collaboration and content development provided by the North Carolina Association of Pharmacists. http://addictionmedicineupdates.org/
Continuing Education:
Correspondence (0.25 hr)
Correspondence (0.25 hr)